Editorial, J Aging Geriatr Med Vol: 8 Issue: 3

Dementia: A Comprehensive Overview

Dr. Daniel Bavisetti^*

Department of Geriatric Medicine, India

*Corresponding Author:

Dr. Daniel Bavisetti
Department of Geriatric Medicine, India
E-mail: danielbavisetti@example.com

Received: 01-May-2025, Manuscript No. agm-25-176129; Editor assigned: 3-May-2025, Pre-QC No. agm-25-176129 (PQ); Reviewed: 17-May-2025, QC No. agm-25-176129; Revised: 24-May-2025, Manuscript No. agm-25- 176129 (R); Published: 31-May-2025, DOI: 10.4172/2576-3946.1000188

Citation: Daniel B (2025) Dementia: A Comprehensive Overview. J Aging Geriatr Med 8: 188

Keywords

Dementia, Alzheimerâ??s disease, Cognitive decline, Neurodegeneration, Aging, Memory loss, Geriatric medicine, Vascular dementia, Lewy body dementia, Neurocognitive disorders

Introduction

Dementia represents a group of neurocognitive disorders that primarily affect older adults and significantly impair cognitive function, behavior, and the ability to perform everyday tasks. Globally, more than 55 million people are living with dementia, a number expected to rise sharply with population aging. Alzheimerâ??s disease accounts for approximately 60 to 70 percent of cases, making it the most common form [1,2].

The onset of dementia is typically insidious, beginning with subtle memory lapses and progressing to profound deficits in language, reasoning, judgment, and psychomotor skills. The condition imposes a major social, emotional, and economic burden on families and healthcare systems [3,4]. While age remains the strongest risk factor, genetics, vascular health, lifestyle patterns, and environmental exposures contribute significantly to disease development.

Early diagnosis is pivotal because it enables better symptom control, advanced care planning, and the implementation of non-pharmacological interventions that help maintain independence. Advances in neuroimaging, biomarkers, and cognitive testing have improved diagnostic accuracy, although curative treatments remain elusive. Management currently focuses on slowing functional decline, addressing behavioral symptoms, and supporting caregivers through multidisciplinary care models [5].

Conclusion

Dementia continues to pose a significant challenge to public health systems as global populations age. Although no definitive cure exists, early recognition and comprehensive care strategies can greatly improve the quality of life for affected individuals. Preventive approaches, such as controlling cardiovascular risk factors, maintaining cognitive and physical activity, and promoting social engagement, are vital in reducing disease risk and progression. Ongoing research into biomarkers, genetics, and novel therapies offers hope for improved outcomes in the coming decades. Collaborative efforts between healthcare providers, policymakers, and caregivers are essential to manage the growing burden of dementia effectively.

References

1. Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, et al. (2005) Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 44: 467-94.

   Indexed at, Google Scholar, Crossref

2. Phan BA, Dayspring TD, Toth PP (2012) Ezetimibe therapy: mechanism of action and clinical update. Vasc Health Risk Manag 8:415-27.

   Indexed at, Google Scholar, Crossref

3. Parthiban C (2022) RP-HPLC Method Development and Validation for the Simultaneous Estimation of Bempedoic Acid and Ezetimibe in Pharmaceutical Dosage Form. IJPPR: December 26: 1.

   Indexed at, Google Scholar, Crossref

4. Jain (2022) Development and Validation of Novel RP-HPLC Method for the Simultaneous Estimation of Ezetimibe and Bempedoic Acid in a Tablet dosage Form. IJPSR 13: 4680-4685.

   Indexed at, Google Scholar, Crossref

5. Kasa, Satla (2022) Validated method for the simultaneous estimation of Bempedoic acid and Ezetimibe in bulk and tablet formulation by RP-HPLC method. World J Pharm Sci 10: 33-41.

   Google Scholar